Angela M. Krackhardt
German Cancer Research Center(DE)Heidelberg University(DE)TUM Klinikum(DE)German Marine Research Consortium(DE)Malteser-Krankenhaus(DE)St. Franziskus Hospital(DE)Technical University of Munich(DE)
Publications by Year
Research Areas
CAR-T cell therapy research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Virus-based gene therapy research
Most-Cited Works
- → Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial(2015)2,648 cited
- → Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma(2019)1,063 cited
- → Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry(2016)705 cited
- → Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy(2016)638 cited
- → Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy(2016)556 cited
- → Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics(2021)189 cited